Early antiviral response in the nose may determine the course of COVID-19

(Broad Institute of MIT and Harvard) How early is the course of COVID-19, mild or severe, determined? In Cell, researchers examined nasal cells sampled from patients at the time of diagnosis, looking for differences between those who developed severe disease and those who experienced a mild illness. Cells from patients who developed severe COVID-19 exhibited a more muted antiviral response. If the early stages of infection can determine disease severity, it opens a path for scientists to develop early therapeutic interventions.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news